Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 16, 2021; 9(26): 7671-7681
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7671
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7671
Table 1 Patient characteristics
n (%) | |
Patients | 138 |
Male | 107 (77.5) |
Age (mean ± SD, yr) | 72.3 ± 10.5 |
PAD | 40 (29.0) |
CBD diameter (mean ± SD, cm) | 1.4 ± 0.6 |
CBD diameter ≥ 1.2 cm | 110 (79.7) |
CBD diameter ≥ 1.5 cm | 73 (52.9) |
Largest CBD stone diameter ≥ 1.2 cm | 68 (49.3) |
CBD stone number ≥ 2 | 56 (40.6) |
Muddy stones | 20 (14.5) |
Initial ampullary intervention | |
EST | 8 (5.8) |
EPBD/EPLBD | 79 (57.2) |
ESBD | 28 (20.3) |
CBD morphology | |
Straight type | 69 (50.0) |
S type | 22 (15.9) |
Polyline type | 47 (34.1) |
Cholecystectomy | 8 (5.8) |
Procedure time (mean ± SD, min) | 38.3 ± 19.5 |
Table 2 Characteristics of patients with and without common bile duct stone recurrence
Recurrence (n = 27) | Non-recurrence (n = 111) | P value | |
Sex (male/female) | 21/6 | 86/25 | 0.97 |
Age (mean ± SD, yr) | 71.9 ± 10.2 | 72.4 ± 10.6 | 0.82 |
PAD, n (%) | 12 (44.4) | 28 (25.2) | 0.05 |
CBD diameter (mean ± SD, cm) | 1.5 ± 0.6 | 1.4 ± 0.4 | 0.29 |
CBD diameter ≥ 1.2 cm, n (%) | 27 (100.0) | 83 (74.8) | < 0.01 |
CBD diameter ≥ 1.5 cm, n (%) | 23 (85.2) | 50 (45.0) | < 0.01 |
Largest CBD stone diameter ≥ 1.2 cm, n (%) | 14 (51.9) | 54 (48.6) | 0.77 |
CBD stone number ≥ 2, n (%) | 13 (48.1) | 43 (38.7) | 0.37 |
Muddy stones, n (%) | 4 (14.8) | 16 (14.4) | 1.00 |
Initial ampullary intervention, n (%) | |||
EST | 2 (7.4) | 6 (5.4) | 1.00 |
EPBD/EPLBD | 15 (55.6) | 64 (57.7) | 0.84 |
ESBD | 6 (22.2) | 22 (19.8) | 0.78 |
CBD morphology, n (%) | < 0.01 | ||
Straight type | 4 (14.8) | 65 (58.6) | |
S type | 12 (44.4) | 10 (9.0) | |
Polyline type | 11 (40.7) | 36 (32.4) | |
Cholecystectomy, n (%) | 3 (11.1) | 5 (4.5) | 0.39 |
Procedure time (mean ± SD, min) | 44.9 ± 22.7 | 36.7 ± 18.4 | 0.05 |
Table 3 Characteristics of patients with different common bile duct morphologies
Straight type (n = 69) | S type (n = 22) | Polyline type (n = 47) | P value | |
Sex (male/female) | 49/20 | 18/4 | 40/7 | 0.19 |
Age (mean ± SD, yr) | 72.6 ± 10.9 | 71.8 ± 10.6 | 72.0 ± 10.0 | 0.93 |
PAD: n (%) | 20 (29.0) | 9 (40.9) | 11 (23.4) | 0.33 |
CBD diameter (mean ± SD, cm) | 1.5 ± 0.5 | 1.8 ± 0.6 | 1.6 ± 0.5 | < 0.01 |
CBD diameter ≥ 1.2 cm, n (%) | 49 (71.0) | 22 (100.0) | 39 (83.0) | < 0.01 |
CBD diameter ≥ 1.5 cm, n (%) | 32 (46.4) | 16 (72.7) | 25 (53.2) | 0.10 |
Largest CBD stone diameter ≥ 1.2 cm, n (%) | 32 (46.4) | 10 (45.5) | 26 (55.3) | 0.59 |
CBD stone number ≥ 2, n (%) | 27 (39.1) | 13 (59.1) | 16 (34.0) | 0.13 |
Muddy stones, n (%) | 12 (17.4) | 2 (9.1) | 6 (12.8) | 0.68 |
Initial ampullary intervention, n (%) | ||||
EST | 3 (4.3) | 2 (9.1) | 3 (6.4) | 0.62 |
EPBD/EPLBD | 39 (56.5) | 14 (63.6) | 26 (55.3) | 0.80 |
ESBD | 15 (21.7) | 3 (13.6) | 10 (21.3) | 0.78 |
Cholecystectomy, n (%) | 3 (4.3) | 2 (9.1) | 3 (6.4) | 0.62 |
Procedure time (mean ± SD, min) | 34.9 ± 15.7 | 49.1 ± 27.8 | 38.4 ± 18.6 | 0.07 |
Table 4 Characteristics of patients with single recurrence and multiple recurrences
Single recurrence (n = 20) | Multiple recurrences (n = 7) | P value | |
Sex (male/female) | 15/5 | 6/1 | 1.00 |
Age (mean ± SD, yr) | 72.7 ± 8.9 | 69.4 ± 13.8 | 0.48 |
PAD, n (%) | 11 (55.0) | 1 (14.3) | 0.09 |
CBD diameter (mean ± SD, cm) | 1.9 ± 0.4 | 2.0 ± 0.8 | 0.73 |
CBD diameter ≥ 1.2 cm, n (%) | 20 (100.0) | 7 (100.0) | |
CBD diameter ≥ 1.5 cm, n (%) | 18 (90.0) | 5 (71.4) | 0.27 |
Largest CBD stone diameter ≥ 1.2 cm, n (%) | 9 (45.0) | 5 (71.4) | 0.39 |
CBD stone number ≥ 2, n (%) | 10 (50.0) | 3 (42.9) | 1.00 |
Muddy stones, n (%) | 4 (20.0) | 0 (0.0) | 0.55 |
Initial ampullary intervention, n (%) | |||
EST | 2 (10.0) | 0 (0.0) | 1.00 |
EPBD/EPLBD | 11 (55.0) | 4 (57.1) | 1.00 |
ESBD | 4 (20.0) | 2 (28.6) | 0.63 |
CBD morphology, n (%) | 1.00 | ||
Straight type | 3 (15.0) | 1 (14.3) | |
S type | 9 (45.0) | 3 (42.9) | |
Polyline type | 8 (40.0) | 3 (42.9) | |
Cholecystectomy, n (%) | 3 (15.0) | 0 (0.0) | 0.55 |
Procedure time (mean ± SD, min) | 45.8 ± 17.0 | 42.4 ± 36.0 | 0.82 |
Follow-up period (mean ± SD, yr) | 19.0 ± 10.6 | 20.1 ± 7.7 | 0.80 |
Table 5 Risk factors for common bile duct stone recurrence
Factor | β | OR (95%CI) | P value | β | OR (95%CI) | P value |
PAD | 0.55 | 1.74 (0.61-4.95) | 0.30 | |||
Procedure time | 0.01 | 1.01 (0.98-1.03) | 0.84 | |||
CBD diameter ≥ 1.5 cm | 1.82 | 6.15 (1.87-20.24) | < 0.01 | |||
Model 1 | Model 2 | |||||
CBD morphology | < 0.01 | < 0.01 | ||||
Straight type | Reference | -1.60 | 0.20 (0.06-0.70) | 0.01 | ||
S type | 2.82 | 16.79 (4.27-66.09) | < 0.01 | 1.22 | 3.38 (1.07-10.72) | 0.04 |
Polyline type | 1.60 | 4.97 (1.42-17.38) | 0.01 | Reference |
- Citation: Ji X, Jia W, Zhao Q, Wang Y, Ma SR, Xu L, Kan Y, Cao Y, Fan BJ, Yang Z. Common bile duct morphology is associated with recurrence of common bile duct stones in Billroth II anatomy patients. World J Clin Cases 2021; 9(26): 7671-7681
- URL: https://www.wjgnet.com/2307-8960/full/v9/i26/7671.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i26.7671